AstraZeneca-Oxford coronavirus vaccine trials to conclude by November, mass production in 2021
https://ift.tt/2ZzrKBJ
The stage 3 clinical trials for the coronavirus vaccine jointly manufactured by the esteemed Oxford University and AstraZeneca will conclude by end of November, an Oxford official has said. The promising data from the initial trials of the vaccine was released a few days ago raising hopes of the vaccine being available by the end of the year.
The stage 3 clinical trials for the coronavirus vaccine jointly manufactured by the esteemed Oxford University and AstraZeneca will conclude by end of November, an Oxford official has said. The promising data from the initial trials of the vaccine was released a few days ago raising hopes of the vaccine being available by the end of the year.
No comments